Provided by Tiger Fintech (Singapore) Pte. Ltd.

10x Genomics, Inc.

14.30
+1.209.16%
Post-market: 14.490.1900+1.33%19:59 EDT
Volume:3.45M
Turnover:48.25M
Market Cap:1.78B
PE:-20.67
High:14.30
Open:13.16
Low:13.11
Close:13.10
52wk High:24.76
52wk Low:6.78
Shares:124.49M
Float Shares:112.38M
Volume Ratio:1.40
T/O Rate:3.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6917
EPS(LYR):-1.5162
ROE:-11.30%
ROA:-9.45%
PB:2.30
PE(LYR):-9.43

Loading ...

Short Squeeze Could Be Giving Stocks a Boost -- Barrons.com

Dow Jones
·
May 13

10x Genomics Is Maintained at Sell by Goldman Sachs

Dow Jones
·
May 13

Stock Track | 10x Genomics Soars 9.75% in Pre-market as Canaccord Genuity Maintains Buy Rating

Stock Track
·
May 12

10x Genomics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
May 12

U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, Comstock, Range Resources

Reuters
·
May 12

10x Genomics Is Maintained at Neutral by JP Morgan

Dow Jones
·
May 10

Stock Track | 10x Genomics Soars 13.56% Pre-market on Earnings Beat and CEO's Candid Remarks on Research Funding Challenges

Stock Track
·
May 09

Stock Track | 10x Genomics Soars 5.10% Pre-market Following Earnings Beat and CEO's Comments on Research Funding Challenges

Stock Track
·
May 09

10x Genomics CEO Calls NIH The 'Foundational Jewel' Of Biomedical Progress, Says 40% To 50% Of Revenue Supported By Academic And Government Research Funding — Pulls Full Year Revenue Guidance

Benzinga
·
May 09

10X Genomics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 09

10x Genomics Q1 EPS $(0.28) Beats $(0.48) Estimate, Sales $154.88M Beat $132.45M Estimate

Benzinga
·
May 09

10x Genomics Reports 10% Revenue Increase in Q1 2025, Net Loss Reduced to $34.4 Million

Reuters
·
May 09

BRIEF-10X Genomics Q1 Revenue USD 154.9 Million Vs. IBES Estimate USD 132.5 Million

Reuters
·
May 09

24H|Crypto Shares Gain; Canaan up 10%; Riot Platforms up 5%; Medical AI Stocks Rise; RXRX up 4%; Gold Shares Fall

Tiger Newspress
·
May 07

Medical AI Stocks Soared. HIMS up 7%; Tempus up 6%; RXRX up 4%; Ginkgo up 3%.

Tiger Newspress
·
May 02

10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks
·
May 01

10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025

PR Newswire
·
Apr 15

Life Sciences Companies Likely to See Surprisingly Good 1Q Results -- Market Talk

Dow Jones
·
Apr 15

BofA Securities Cuts Price Target on 10x Genomics to $12 From $16, Neutral Rating Maintained

MT Newswires Live
·
Apr 14